Life sciences briefing: Wednesday, Jan. 2, 2008
TODAY’S HEADLINES:
Israel’s Alma Lasers files for $86M IPO (Edgar)
Allscripts acquires hospital-management software co. ECIN for $90M (release)
AgaMatrix, glucose-sensor maker, raises $24M (PE Hub)
Israel’s Alma Lasers files for $86M IPO — Alma Lasers, an Israeli maker of lasers for cosmetic procedures, filed to raise $86.3 million in an initial offering. The company, based in Caesarea, calls its products “energy-based aesthetic treatment systems,” and sells them to dermatologists for hair removal and wrinkle treatment.
Alma markets its products… Continue Reading
Life sciences briefing: Friday, Oct. 26, 2007
Featured companies: Allozyne, Arteriocyte Medical Systems, Arthrosurface, Bay City Capital, EnteroMedics, OncoVista, Novotech, Power Medical Interventions, Reliant Technologies
UPDATED: Expanded items on Allozyne, Reliant Tech, Power Medical and Bay City Capital.
UPDATE REDUX: Added item on EnteroMedics IPO.
Seattle’s Allozyne draws $30M for new interferon — Allozyne, a Seattle biotech focused on tweaking existing protein-based drugs to improve their properties, raised $30 million in a second round of financing. Investors included MPM Capital, OVP Venture Partners, Amgen Ventures, ARCH Venture… Continue Reading